Allergan PLC on Thursday won its last-minute bid at a federal appeals court to delay a trial set for next week in a class action lawsuit claiming it suppressed generic competition for its ulcerative colitis drug Asacol.
The 1st U.S. Circuit Court of Appeals in Boston ordered lower-court proceedings in the case be put on hold while it reviews a judgeâ€™s decision to certify a class of health plans and other indirect drug purchasers.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2GhrXxv
 